FY25 revenue consensus $411.67M. Still sees FY25 adjusted net income positive for each quarter and for full year, consensus $1.80.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGS:
- WGS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Apple upgraded, Rivian downgraded: Wall Street’s top analyst calls
- GeneDx granted breakthrough device designation for whole genome, exome tests
- GeneDx initiated with a Buy at Canaccord
- WGS, PONY, QSI, SLMT: Cathie Wood Snaps Up Biotech and AI Stocks, Trims Stake in a Semiconductor Name
